svg-arrow-next svg-arrow-prev
×

Order online: 0917-565-3700/ 0998-530-3700

sidebar

Augmentin 375mg 1 Tablet

(No reviews) Write a Review
₱51.25
  per tablet

SKU:
002739
Generic Name:
Co-Amoxiclav


Note: Uploaded prescription slip is subject to validation by our Pharmacist.

file types are bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff

Augmentin 375mg 1 Tablet

₱51.25

Augmentin 375mg 1 Tablet

₱51.25

file types are bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff

IMPORTANT NOTICE:
For this product, a doctor's prescription is required. Please do not forget to attach a copy of your valid prescription(.jpeg, bmp, gif, jpg, jpeg, jpe, jif, jfif, jfi, png, wbmp, xbm, tiff format). After you have placed your order, our pharmacist will be in touch to confirm your order and validate your prescription. Please present the original copy of your prescription upon the arrival of your order.

An item like loose capsule/tablets, ampules, vials, and refrigerated items is not subject for merchandise return or exchange upon completing the purchase.

PRODUCT DETAILS  
   
Brand Name Augmentin 375 mg Tablet
Generic Name Co-amoxiclav
Strength Co-amoxiclav (Augmentin) 375 mg Tablet: Each tablet contains 250 mg amoxicillin and 125 mg clavulanic acid.
Dosage Form Tablet
Indication/Usage Co-amoxiclav (Augmentin) should be used in accordance with local official antibiotic-prescribing guidelines and local susceptibility data.
Co-amoxiclav (Augmentin ES) is indicated for the short-term treatment of bacterial infections in paediatric patients at the following sites when caused by Co-amoxiclav (Augmentin)-susceptible organisms: Upper respiratory tract infections (including ENT) e.g. recurrent or persistent acute otitis media due to Streptococcus pneumoniae (penicillin minimum inhibitory concentration (MIC) less than or equal to 4 μg/mL), Haemophilus influenzae and Moraxella catarrhalis. Such patients are often characterised by antibiotic exposure for acute otitis media within the preceding 3 months, and are either aged ≤2 years or attend daycare; tonsillo-pharyngitis and sinusitis, typically caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pyogenes.
Lower respiratory tract infections e.g. lobar and bronchopneumonia typically caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Dosage and Administration Dosage depends on the age, weight and renal function of the patient and the severity of the infection.
Dosages are expressed throughout in terms of co-amoxiclav content except when doses are stated in terms of an individual component.
Therapy can be started parenterally and continued with an oral preparation.
Warning and Precautions Before initiating therapy with Co-amoxiclav (Augmentin), careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens.
Serious and occasionally fatal hypersensitivity (anaphylactoid) reactions have been reported in patients on penicillin therapy. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity. If an allergic reaction occurs, Co-amoxiclav (Augmentin) therapy should be discontinued and appropriate alternative therapy instituted. Serious anaphylactoid reactions require immediate emergency treatment with adrenaline. Oxygen, IV steroids and airway management, including intubation may also be required.
Co-amoxiclav (Augmentin) should be avoided if infectious mononucleosis is suspected since the occurrence of a morbilliform rash has been associated with this condition following the use of amoxicillin.
Prolonged use may also occasionally result in overgrowth of non-susceptible organisms.
Contraindication Co-amoxiclav (Augmentin) is contraindicated in patients with a history of hypersensitivity to beta-lactams e.g. penicillins and cephalosporins; in patients with a previous history of amoxicillin-clavulanate-associated jaundice/hepatic dysfunction.
Requires prescription? Yes
Storage Conditions Store at temperatures not exceeding 30°C.
Regulatory Classification Prescription Drug

Related Products

Be a member